Template:Hyperlipoproteinemia: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
Tarek Nafee (talk | contribs) No edit summary |
||
(4 intermediate revisions by one other user not shown) | |||
Line 11: | Line 11: | ||
|- bgcolor="LightGrey" | |- bgcolor="LightGrey" | ||
|- bgcolor="Pink" | |- bgcolor="Pink" | ||
Line 38: | Line 33: | ||
! | ! | ||
[[Hyperlipoproteinemia#Classification|Classification]] | [[Hyperlipoproteinemia#Classification|Classification]] | ||
:'''[[Familial hyperchylomicronemia]]''' | |||
:'''[[Familial hypercholesterolemia]]''' | |||
:'''[[Familial combined hyperlipidemia]]''' | |||
:'''[[Dysbetalipoproteinemia]]''' | |||
:'''[[Primary hypertriglyceridemia]]''' | |||
[[ | :'''[[Mixed hyperlipoproteinemia]]''' | ||
|- | |- | ||
! | ! | ||
Line 50: | Line 45: | ||
! | ! | ||
[[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]] | [[Hyperlipoproteinemia#Differential Diagnosis|Differential Diagnosis]] | ||
|- | |- | ||
! | ! | ||
Line 62: | Line 51: | ||
! | ! | ||
[[Hyperlipoproteinemia#Screening|Screening]] | [[Hyperlipoproteinemia#Screening|Screening]] | ||
|- | |- | ||
! | ! |
Latest revision as of 14:41, 3 March 2017
Hyperlipoproteinemia Microchapters |
ACC/AHA Guideline Recommendations |
Intensity of statin therapy in primary and secondary prevention |